QUOTED. 18 March 2021. Larry Biegelsen.
The US Centers for Medicare and Medicaid Services (CMS) has decided to delay a highly anticipated rule that would have automatically qualified certain breakthrough medical devices for Medicare reimbursement. See what Wells Fargo’s analyst Larry Biegelsen wrote about it here.
“Our sense is that this notice and delay from CMS was a surprise to stakeholders. We believe the MCIT pathway has bipartisan support, however, at this time we cannot handicap how this delay may affect its final passage and implementation.” – Larry Biegelsen, analyst, Wells Fargo
- Find out more: CMS Pauses The Clock On Implementing Highly Anticipated Medical Device Reimbursement Rule
Click here for a free trial of Medtech Insight